NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced late Wednesday that it has priced an offering of $1.2 billion aggregate principal amount of its 2.950 percent senior notes due 2026 at the issue price of around 98.8 percent of the principal amount.

The issuance is expected to close on or about Sept. 19, and the firm said it plans to use much of the proceeds to redeem all of the outstanding $900 million aggregate principal amount of its 1.30 percent senior notes due 2017, which mature on Feb. 1, 2017. The remaining proceeds will be used for general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.